On Wednesday, US President Joe Biden publicly embraced the conspiracy theory that COVID-19 may have been released from China’s Wuhan Institute of Virology, ordering the US intelligence agencies to produce a report within 90 days into the potentially man-made origins of the disease.
Share this article
Share this article
TEL AVIV, Israel and RALEIGH, NC, May 26, 2021 /PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ( RedHill or the Company ), a specialty biopharmaceutical company, today announced receipt of two Notices of Allowance from the U.S. Patent and Trademark Office (USPTO) covering opaganib
[1] and RHB-107 (upamostat)
[2] as methods for the treatment of COVID-19 caused by the SARS-CoV-2 virus.
Both opaganib and RHB-107 are novel COVID-19 therapeutic candidates, in oral pill form, with dual mechanism of action effects. Both are host-targeted and are therefore expected to be effective against emerging viral variants with various mutations in the spike protein.
RedHill Biopharma Receives Allowances for U S Patent Applications Covering Opaganib and RHB-107 for COVID-19 yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Incredibly Unwell India
With bacterial diseases emerging that are increasingly resistant to antibiotics, governments should step up monitoring, develop new lines of treatment and prevent overuse. In his column for Businessworld, YaleGlobal Editor Nayan Chanda points out how a manufacturing hub for a product encourages consumer use: “The rise of the country’s $12.4 billion pharmaceutical industry, producer of nearly one-third of the world’s antibiotics, has seen the proliferation of powerful generic drugs to every corner of India. Until recently, local chemists in any small town would hand strips of antibiotics, without a prescription, to customers complaining of common ailments like diarrhea, fever or cough.” As a result, researchers have identified India as a source for some superbugs: Up to 90 percent of Indians could have drug-resistant bacteria in their bodies, generally harmless for them but a threat for foreign visitors. India set up a task force and now requires presc